Creades AB (CRED-A) Fair Value & Analysis
Financial Services · SE · Market cap 11.4B SEK
Fair value as of: Jul 18, 2026
From 22 valuation models · updated 3 days ago
Share price +5.4% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 64.34 – kr 84.90 · fair‑value band kr 113.92 – kr 189.86 · the kr 82.40 price screens below the kr 151.89 fair value. As of Jul 18, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Creades AB (CRED-A) currently trades at kr 82.40, while our model-based Fair Value estimate is kr 151.89, implying the stock looks roughly 84.3% undervalued today. We read business quality at 69/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Creades AB generated revenue of 616M SEK at a net margin of 90.4%. Revenue declined 45.6% year over year. It earns a return on equity of 5.3%. The balance sheet holds a net cash position of 279M SEK. Fundamentals as of Jul 18, 2026
Our scenario range runs from kr 113.92 (bear case) to kr 189.86 (bull case); at kr 82.40, the current price sits below that range. The share trades about 1% below its 52-week high and 33% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 53% fair-value upside, at 84%, CRED-A screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.
About the company
Creades AB is a private equity and venture capital investment firm specializing in early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK50 million ($4.78 million) and SEK500 million ($47.91 million). The firm can take both majority and minority stakes and also a seat on the board of directors of its portfolio companies. The firm uses personal and balance sheet capital for making investments. Creades AB was founded in 2011 and is based in Stockholm, Sweden.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Creades AB reported revenue of kr 110M in FY2025 versus kr 4.5B in FY2021, a compound −60.4%/yr. Reported net income was kr 1.2B in FY2025, compounding −26.7%/yr from FY2021.
Is CRED-A fairly valued? → Check now
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $4.20 | $6.41 | +53% |
| The Schiehallion Fund Limited MNTN | $0.0214 | $0.0400 | +87% |
| BlackRock, Inc UU2 | €923.80 | €569.37 | -38% |
| Blackstone Inc BX | $123.26 | $52.88 | -57% |
| BH Macro Limited BHMU | $0.0442 | $0.0900 | +104% |
| Investor AB INVEB | kr 388.65 | kr 1,430 | +268% |
| BioPharma Credit PLC BPCR | $0.0095 | $0.0200 | +111% |
| Brookfield Corporation BN | $43.94 | $9.95 | -77% |
| KKR & Co KKR | $96.90 | $61.30 | -37% |
| Brookfield Asset Management Ltd BAM | C$66.82 | C$34.17 | -49% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Creades AB (CRED-A) undervalued?
What is the fair value of CRED-A?
What is the quality score of CRED-A?
What is the revenue of Creades AB (CRED-A)?
What is the net profit margin of CRED-A?
Does Creades AB pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Creades AB analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.